Endocannabinoids (ECBs) depress transmitter release at sites throughout the brain. Here, we describe another form of ECB signaling that triggers a novel form of long-term potentiation (LTP) localized to the lateral perforant path (LPP) which conveys semantic information from cortex to hippocampus. Two cannabinoid CB 1 receptor (CB 1 R) signaling cascades were identified in hippocampus. The first is pregnenolone sensitive, targets vesicular protein Munc18-1 and depresses transmitter release; this cascade is engaged by CB 1 Rs in Schaffer-Commissural afferents to CA1 but not in the LPP, and it does not contribute to LTP. The second cascade is pregnenolone insensitive and LPP specific; it entails co-operative CB 1 R/β1-integrin signaling to effect synaptic potentiation via stable enhancement of transmitter release. The latter cascade is engaged during LPP-dependent learning. These results link atypical ECB signaling to the encoding of a fundamental component of episodic memory and suggest a novel route whereby endogenous and exogenous cannabinoids affect cognition.
Introduction
The granule cells of the hippocampal dentate gyrus (DG) are densely innervated by the superficial layers of the lateral and medial entorhinal cortices (Amaral and Lavenex 2007) , which convey information about the nature of cues and their location in space (Eichenbaum and Fortin 2005) . The granule cells then relay information to the CA3 pyramidal cells that generate a massive associational (CA3-CA3) system (Witter 2007) ; recording studies from rodents suggest that this region incorporates data relating to when the cues occurred (Salz et al. 2016) . CA3 also gives rise to the very large Schaffer-Commissural (S-C) projection to pyramidal neurons in field CA1, where further integration likely occurs. CA1 directly and through intermediaries innervates the deep layers of entorhinal cortex (Amaral and Lavenex 2007) . It is widely held that through this circuitry the hippocampus converts a sequence of inputs from cortex into representations that include semantic, spatial, and temporal components (Aggleton and Brown 1999; Eichenbaum 2000) . Multiple studies suggest that transmission of this code back to cortex is essential for the construction and retrieval of episodic memory, a fundamental ingredient of orderly thought (Eichenbaum et al. 2012) .
Consistent with this role, each of the above hippocampal connections undergoes stable potentiation of synaptic transmission, long-term potentiation (LTP), following brief periods of afferent stimulation including activity patterns exhibited during learning. Much has been learned about the synaptic events that induce, express, and rapidly consolidate the potentiated state, particularly for the CA3-CA1, S-C connection: enduring changes occur postsynaptically and involve reorganization of the spine cytoskeleton, enlargement of the postsynaptic density, and an increase in membrane neurotransmitter receptors Granger and Nicoll 2014) . Appreciation of how hippocampus executes its memory encoding operations will depend on the extent to which other connections in the circuit use this or other forms of plasticity. Recent work suggests that pronounced pathway-specific differences are in fact present. Specifically, the lateral perforant path (LPP) afferents from lateral entorhinal cortex to the DG exhibit a form of potentiation that depends on postsynaptic induction but is expressed presynaptically as an increase in evoked transmitter release (Wang et al. 2016) . The retrograde messenger required by this arrangement proved to be the endocannabinoid (ECB) 2-arachidonoylglycerol (2-AG) which is synthesized in dendritic spines and diffuses to CB 1 receptors (CB 1 Rs) on axon terminals. The 2-AG system is present at many types of synapses where its direct retrograde signaling has been shown to transiently depress release (Diana and Marty 2004; Castillo et al. 2012) ; nevertheless, it serves the very different purpose of promoting potentiation of transmission in the LPP.
Recent studies demonstrated that presynaptic signaling through ERK1/2 to the vesicular protein Munc18-1 is critical for CB 1 R-mediated depression of release (Schmitz et al. 2016) . Here, we show that CB 1 R agonists readily activate this signaling cascade at S-C synapses but not in the LPP. Instead, at LPP terminals the CB 1 R/2-AG system is biased toward a second cascade involving β1 integrins and presynaptic actin regulatory signaling. The finding that a specialized form of synaptic potentiation is used to encode semantic information processed by hippocampus calls for substantial revisions to current hypotheses about how the structure contributes to the formation of memory. It also provides a new perspective for understanding the abnormal encoding of episodes produced by cannabinoid drugs.
Materials and Methods
All studies used male rats and mice that were group housed (≤5 per cage) on a 12 h on/12 h off light cycle with food and water ad libitum. Excepting animals used for behavioral studies, the lights were turned on at 6:30 AM; for behavioral groups lights were turned on at 8 PM. Experiments were initiated from 8 to 10 AM for electrophysiology and for treatments leading to biochemical measures, and from 9 to 10 AM for behavioral studies. All animals were naïve to treatment prior to the procedures described.
Hippocampal Slices and Extracellular Field Recordings
Animals used for extracellular field recordings were 5-to 8-week-old male rats (Sprague-Dawley; Harlan Laboratories) and mice. The mice included (1) Munc18-1 heterozygote knockouts (KOs) (Munc18-1 +/− ; a.k.a. STXBP1 from Riken labs) and background strain (C57BL/6N) matched wild types for comparison, and (2) conditional β1-integrin KOs created by crossing mice with floxed β1-integrin exon 3 with mice expressing Crerecombinase under control of the CaMKIIα promoter (Mortillo et al. 2012; Wang et al. 2016a) ; in the progeny the expression of Cre by excitatory hippocampal and cortical neurons (Tsien et al. 1996) leads to excision of β1 exon 3 and disruption of β1 protein expression beginning at 3 weeks of age. The present studies used β1 KOs at 8 weeks of age. The preparation of hippocampal slices and their maintenance in an interface recording chamber has been described in detail elsewhere (Trieu et al. 2015; Wang et al. 2016 ). Animals were killed by decapitation under deep isofluorane anesthesia and the brain was quickly submerged into oxygenated, ice-cold, high-magnesium artificial cerebral spinal fluid (ACSF) containing (in mM): 124 NaCl, 3 KCl, 1.25 KH 2 PO 4 , 5 MgSO 4 , 26 NaHCO 3 , and 10 dextrose. For rats, slices from the middle third of the hippocampal septotemporal axis were sectioned at a thickness of 330-400 μm using a McIlwain tissue chopper; for mice 375 μm thick sections were prepared on the horizontal plane using a Leica Vibrating Slicer (Model: VT1000S). In both cases, slices were collected into oxygenated, high-magnesium ACSF and then transferred onto an interface recording chamber (31 ± 1°C; 95% O 2 /5% CO 2 ) and continuously perfused with preheated oxygenated ACSF containing (in mM): 124 NaCl, 3 KCl, 1.25 KH 2 PO 4 , 1.5 MgSO 4 , 26 NaHCO 3 , 2.5 CaCl 2 , and 10 dextrose at a rate of 60-70 ml/h. Experiments were initiated about 1.5 h after slices were placed on the recording chamber.
Field excitatory postsynaptic potentials (fEPSPs) were recorded by positioning a glass recording electrode (filled with 2M NaCl; 2-3 MΩ) and bipolar stimulating electrode (twisted nichrome wire 65 μm) in 2 hippocampal pathways (Trieu et al. 2015) . For studies of the LPP innervation of the DG, recording and stimulating electrodes were both positioned in the outer molecular layer (internal blade), adjacent to the hippocampal fissure. All evoked responses were initially tested with pairedpulse stimuli (40 and 200 ms interpulse interval) to confirm specificity of potentials and thus electrode placement: LPP responses show paired-pulse facilitation whereas the adjacent medial perforant path shows paired-pulse depression (Christie and Abraham 1994) . For studies of S-C innervation of field CA1 stratum radiatum, recording and stimulating electrodes were positioned in CA1b and CA1c, respectively, at comparable distance from the pyramidal cell layer. Test pulses were delivered at 0.05 Hz and baseline stimulation intensity was adjusted to 50-60% of the maximum spike-free fEPSP. Stable baseline recordings were collected for at least 20 min prior to pharmacological manipulation or induction of LTP. For the LPP, LPT was induced using 1 of 2 paradigms: (1) two 100 Hz trains, lasting 1 s and separated by 1 min with stimulus duration and intensity increased to 100% and 50% above baseline levels, respectively, and (2) one 100 Hz train, lasting 1 s, no current changes (termed "threshold level" stimulation). Stimulus strength was returned to baseline levels after induction. LTP in field CA1 was induced using one 100 Hz trains, lasting 1 s. The level of potentiation was assessed using 0.05 Hz pulses (i.e., baseline stimulation parameters) delivered for ≥1 h after inducing stimulation.
In all instances, initial slopes and amplitudes were measured from digitized fEPSPs (NACGather 2.0, Theta Burst Corp.) and normalized to mean responses over the last 20 min of the baseline period. Assessments of the level of potentiation were made for the period from 50 to 60 min after delivery of the inducing 100 Hz stimulation. For analysis of pharmacological treatment effects on synaptic responses, statistical tests considered slice mean responses over the last 5 min of the recording period unless otherwise specified.
Whole-Cell Recordings
Hippocampal slices were prepared on the horizontal plane at a thickness of 370 μm from 3-to 4-week-old male rats with a Leica vibrating tissue slicer (Model: VT1000S). Slices were placed in a submerged recording chamber and continuously perfused at 2-3 mL/min with oxygenated (95% O 2 /5% CO 2 ) at 32°C. Whole-cell recordings (Axopatch 200A amplifier: Molecular Devices) were made with 4-7 MΩ recording pipettes filled with a solution containing (in mM): 130 CsMeSO 4 , 10 CsCl, 8 NaCl, 10 HEPES, 0.2 EGTA, 5 QX-314, Mg-ATP, 0.3 Na-GTP. Osmolarity was adjusted to 290-295 mOsm and pH 7.4. Bipolar stimulating electrodes were placed in the outer molecular layer to stimulate the LPP. Excitatory postsynaptic currents (EPSCs) were recorded by clamping the granule cell at −55 mV and confirmed with AP5 and CNQX application. Inhibitory postsynaptic currents (IPSCs) were recorded at holding potential of 0 mV and confirmed with bicuculline application.
Drug Application
For hippocampal slice experiments, compounds were introduced to the bath (6 mL/h) via an independent perfusion line using a syringe pump (KD Scientific). Field recording studies used the CB 1 R inverse agonist AM251 (5 μM), CB 1 R agonist WIN 55, 212-2 mesylate (5 μM), H1152 (0.1 μM), focal adhesion kinase (FAK) Inhibitor 14 (Y15, 40 μM), GM 6001(25 μM), physostigmine hemisulfate (10 μM), and pregnenolone sulfate sodium salt (10 μM), purchased from Tocris Bioscience. The latter 2 were dissolved in water; others were dissolved in dimethyl sulfoxide (DMSO) and diluted in ACSF to achieve the final concentration and ≤0.01% DMSO in the ACSF bath. Integrin-targeted reagents were applied locally by pressure ejection ; these included echistatin (E1518, Sigma-Aldrich, 10 μM) and neutralizing antisera to β1 and αV integrin (MAB1987Z and CBL1346Z, respectively; 0.2 mg/mL; EMD Millipore). For some experiments, GABAA receptor antagonist picrotoxin (PTX) (Sigma-Aldrich) was introduced to the slice bath via the main ACSF perfusion line. For intraperitoneal injections, rats were given AM251 (1 mg/kg, 40 min before test) dissolved in DMSO, cremophore, ethanol, 0.9% saline (1:1:1:17) or vehicle.
Lipid Quantification
Levels of 2-AG, oleoylethanolamide (OEA), arachidonic acid, and stearic acid were determined using liquid chromatography/mass spectrometry (LC/MS) methods (Jung et al. 2007 ). For analysis of effects of physostigmine treatment, the hippocampal slices were quickly snap-frozen and then homogenized in methanol containing appropriate internal standards. Protein concentration was determined using the bicinchoninic acid protein assay (Pierce). Lipids were extracted with chloroform, and further fractionated by open-bed silica gel column chromatography. The eluates were dried under N 2 and reconstituted in chloroform/methanol for LC/MS analyses as described (Jung et al. 2012) . To quantify levels of 2-AG and OEA, we used an Agilent 1200 LC system coupled to a 6410 triple quadrupole MS system (Agilent Technologies). Lipids were separated using a XDB Eclipse C18 column (50 × 4.6 mm i.d., 1.8 μm, Zorbax, Agilent), eluted with a gradient of methanol in water (from 90% to 100% in 5 min, to 100% in 7 min, and to 90% in 8 min) at a flow rate of 1 mL/min. Column temperature was held at 40°C. MS detection was in electrospray ionization (ESI) and positive ionization mode, with capillary voltage at 3.5 kV and fragmentor voltage at 135 V. N2 was used as drying gas at a flow rate of 12 L/min and temperature of 350°C. Nebulizer pressure was set at 50 psi. Quantifications were conducted by an isotope dilution method, monitoring [M+H] + in the selected ion monitoring (SIM) mode. The multiple reaction transitions monitored were as follows: 2-AG, m/z 379→287; 2 H 8 -2-AG, m/z 387→295; OEA, m/z 326→62; 2 H 4 -OEA, m/z 330→66 (m/z, mass-to-charge ratio). Detection and analysis were performed using Mass Hunter Workstation software (Agilent). Levels for free fatty acids were determined by LC/MS methods (Jung et al. 2007 ) using an Agilent 1100-LC system (Agilent Technologies) coupled to a 1946A-MS detector equipped with ESI interface (Agilent Technologies). For fatty acids, mobile phase A consisted of methanol containing 0.25% acetic acid and 5 mM ammonium acetate; mobile phase B consisted of water containing 0.25% acetic acid and 5 mM ammonium acetate. We used a reversed-phase Zorbax XDB Eclipse C18 column (50 × 4.6 mm i.d., 1.8 m, Agilent Technologies) eluted with a linear gradient from 90% to 100% of A in B for 2.5 min at a flow rate of 1.5 mL/min with column temperature at 40°C. ESI was in the negative mode, capillary voltage was set at 4 kV, and fragmentor voltage was 100 V. N 2 was used as drying gas at a flow rate of 13 L/min and a temperature of 350°C. Nebulizer pressure was set at 60 psi. Fatty acids are measured by monitoring the mass-tocharge ratio (m/z) of deprotonated molecular ions [M-H] − in SIM mode: for oleic acid, m/z = 281 and for heptadecanoic acid, m/z = 269. We used commercially available fatty acids as reference standards. Detection and analysis were performed using Agilent Chemistation and Bruker Daltonics software. Calibration curves were generated using commercial fatty acids. Limit of quantification was 0.5 pmol.
Fluorescence Deconvolution Tomography/ Quantification of Immunolabeling
Measures were collected from hippocampal slices given either LTP-inducing or low-frequency stimulation (LFS), and from brains of animals given odor discrimination training. For the slice studies, the tissue was immersion fixed in 4% paraformaldehyde and sectioned (20 μm) on a freezing microtome, and then the top 6 sections (from the surface of electrode placement) were slide mounted and processed for immunofluorescence (Seese et al. 2012) . For behavioral studies, rats were euthanized immediately after the last trial and brains were then quickly frozen in 2-methylbutane (−55°C), cryostat-sectioned (20 μm), and 3 sets of tissue sections were collected with 300 μm spacing between sections in each set. Separate spans of sections were collected from the septal, mid-septo-temporal, and temporal regions of hippocampus, with the section angle adjusted for each to remain approximately perpendicular to the long axis of hippocampus. The microscope slide mounted tissue was fixed in 4% paraformaldehyde and processed for immunostaining as described (Seese et al. 2014) . Immunofluorescence procedures used cocktails of primary antisera (Table 1) including rabbit antisera to pMunc18-1 Ser241 (Schmitz et al. 2016) , phosphorylated proline-rich tyrosine kinase 2 (pPyk2) Tyr402 (Zhao et al. 2000) , phosphorylated RhoA associated coiled coil containing kinase 2 (pROCK2) Ser1366 (Chuang et al. 2012) , or pFAK Y397 (Bock and Herz 2003) , used in combination with mouse antisera to synaptophysin (SYN) (Wen et al. 2014) or postsynaptic density protein-95 (PSD-95) (Takahashi et al. 2011) ; or guinea pig anti-vGluT2 used in combination with rabbit anti-CB 1 (Matyas et al. 2006 ) that was generously provided by Dr Ken Mackie of Indiana University. Secondary antisera from ThermoFisher Scientific included Alexa Fluor 594 antirabbit IgG (A21207), Alexa Fluor 488 anti-mouse IgG (A21202) and Alexa Fluor 488 anti-guinea pig IgG (A-11073) all used at 1:1000 dilutions. An epifluorescence microscope (Leica DM6000) with a 63× PlanApo objective and ORCA-ER camera (Hamamatsu) was used to capture image z-stacks, through a depth of 2 μm in 0.2 μm z-steps, from the DG outer molecular layer and CA1 stratum radiatum. For slice experiments, 1 z-stack was captured from each of 6 sections per slice. For behavioral/brain studies, 3 z-stacks were captured per section from 3 to 4 spaced sections within a given septo-temporal span of hippocampus (described above). Immunolabeling for the synaptic vesicle protein SYN and for the excitatory synapses postsynaptic scaffold protein PSD-95 served as markers for the presynaptic and postsynaptic compartment, respectively. The incidence and density of immunolabeling for the phosphoprotein co-localized with these compartment markers were then evaluated using widefield epifluorescence microscopy and fluorescence deconvolution tomography (FDT) as described elsewhere (Seese et al. 2012 (Seese et al. , 2013 . Briefly, images within each z-stack were processed for iterative deconvolution (99% confidence, Volocity 4.0, PerkinElmer) and then used to construct a 3-dimensional (3D) montage of the sample field. Automated systems (Rex et al. 2009; Seese et al. 2012) were then used to normalize background density, identify immunolabeled elements within the size and eccentricity constraints of synapses, and quantify (count and measure fluorescence intensity) those double-labeled. Elements were considered double-labeled if there was any overlap in the field labeled with the 2 fluorophores as assessed in 3D.
Odor Discrimination Behavior
Male Long-Evans rats (6-10 week old) were handled for 6 sessions, 2 sessions per day, and prior to odor discrimination training. Procedures for animal handling, training, and testing were adapted from Martens et al. (2013) as described in detail elsewhere (Wang et al. 2016) . Sessions of ten 30 s trials on a given odor pair were repeated up to twice daily until rats reached a success rate of 80% correct (i.e., selection of the odor scented cup associated with a food reward) at which point they were considered to have acquired the odor discrimination task. On the following day, trained rats were either given 10 training trials on a novel odor pair (learning group) or transported to but not placed in the test apparatus (control group), and killed immediately thereafter for tissue harvest (ten trials are sufficient for rats that have acquired the task to learn a novel odor pair; Wang et al. 2016 ).
Statistical Analyses
All results are presented as means ± SEM. Statistical significance (P < 0.05) was evaluated using Student's t-test, 1-way or 2-way analysis of variance (ANOVA) with a Bonferroni post hoc test. In all cases analyses used Prism software (GraphPad) that provides evaluation of the suitability of the test for the specific data set.
Results

CB 1 R / Munc18-1 Signaling is Markedly Different in 2 Hippocampal Pathways
The CB 1 R is found on axon terminals throughout the brain (Katona et al. 2006; Uchigashima et al. 2011) including the field of LPP termination in the outer molecular layer of the DG (Wang et al. 2016 ). We confirmed CB 1 R localization to glutamatergic (i.e., VGluT2 immunopositive [+]) terminals in the rat LPP field and then compared the effects of cannabinoid receptor agonist WIN 55,212-2 (WIN) on synaptic physiology in the S-C and LPP projections. In accord with prior work (Paton et al. 1998; Schmitz et al. 2016) , WIN (5 μM) caused a rapid and pronounced depression of S-C fEPSPs in CA1 (P < 0.0001; Fig. 1a ) that was accompanied by an increase in paired-pulse facilitation (P = 0.0067; Fig. 1b ) and the expected severe impairment of LTP (P < 0.0001; Fig. 1c ). Very different results were obtained in the LPP: WIN had no effect on baseline fEPSPs or on pairedpulse facilitation (Fig. 1d,e) . Voltage-clamp recordings also detected no effect on EPSCs in the LPP (see Supplementary  Fig. S1 ). In contrast to these results for glutamatergic responses in the LPP, WIN produced the canonical depression of IPSCs elicited by single pulse LPP stimulation (P = 0.0004; Fig. 1f ). We next asked if, despite the lack of effect on baseline responses, WIN influences the machinery that produces the ECBdependent potentiation of the LPP (lppLTP) using stimulation that is near threshold for induction. WIN more than doubled the magnitude of lppLTP under these conditions (P = 0.0054; Fig. 1g ). These results suggest that activation of CB 1 Rs in the LPP preferentially engages signaling mechanisms leading to potentiated transmission as opposed to the more commonly observed depression of release.
CB 1 R signaling through ERK1/2 effects phosphorylation and degradation of the vesicular protein Munc18-1 leading to reductions in transmitter release (Schmitz et al. 2016) . In accord with this, using dual immunofluorescence and FDT (Fig. 1h) , we found that treatment with WIN increased levels of phosphorylated (p) Munc18-1 S241 co-localized with the presynaptic marker SYN in the S-C terminal field: WIN caused both a rightward shift in the pMunc18-1 immunolabeling intensityfrequency distribution (P < 0.0001; Fig. 1i ) and increased numbers of terminals with dense pMunc18-1 immunoreactivity (P = 0.0037; Fig. 1j left) . In the same slices, WIN had no effect on presynaptic pMunc18-1 immunolabeling in the LPP terminal field (Fig. 1j right) . The above results indicate that WIN-initiated CB 1 R signaling at LPP terminals is biased "away from" the ERK1/2-to-Munc18-1 cascade through which ECBs suppress neurotransmitter release and toward a route that promotes plasticity. They also raise the question of whether signaling to Munc18-1 and release suppression in CA1 is engaged by normally occurring patterns of physiological activity. Blocking the CB 1 R with the inverse agonist AM251 had no effect on S-C fEPSPs elicited by single pulses (0.05 Hz). Thus, we tested for an effect using short trains of low-frequency gamma (40 Hz) stimulation. This pattern occurs routinely in hippocampal and entorhinal fields in behaving animals and is thought to be associated with processing of complex information (Colgin 2015) . Within-slice comparisons were made between responses collected before and after 40 min perfusion of vehicle or 5 μM AM251. In CA1, S-C responses to low gamma stimulation showed the rapid, within-train frequency facilitation described in prior work (Trieu et al. 2015) (Fig. 2a) . AM251 did not affect baseline responses but clearly enhanced S-C response facilitation during the gamma train (mean facilitation over the last five pulses; P = 0.021; Fig. 2b ). Effects of AM251 were greatest in later portions of the train, as anticipated for contributions of "on-demand" ECB production. Very different results were obtained for the LPP. Within-train facilitation was less pronounced in the LPP than in the S-C system, and this effect was not altered by AM251 (Fig. 2c,d ). These findings are consistent with the hypothesis that CB 1 R signaling leading to a depression of transmitter release is more readily engaged in the S-C projections than in the LPP.
Pregnenolone-Sensitive Munc18-1 Phosphorylation does not Contribute to lppLTP
The above results were unexpected because prior studies showed that physostigmine causes a suppression of excitatory transmission in the LPP and other hippocampal pathways that is blocked by AM251 (i.e., it is CB 1 R-dependent) (Colgin et al. 2003) . the presence of 100 μM PTX had no effect on LPP baseline responses (P = 0.23, t(11) = 1.27) or (e) paired-pulse facilitation (P = 0.88, t(12) = 0.15; 40 ms interpulse interval).
(f) Voltage-clamp recordings (HP = 0 mV) show that WIN attenuates IPSCs recorded from DG granule cells with LPP stimulation (P = 0.0004, t(10) = 5.15; mean ± SEM for 6 cells). Traces are representative responses collected before (control) and 20 min after WIN infusion onset. Later elimination of the response by bicuculline confirmed it was GABA receptor-mediated. (g) WIN infusion (at bar) enhanced the magnitude of lppLTP induced with near threshold stimulation with 100 μM PTX present (P = 0.0054, t(11) = 3.45). (h,i) Representative deconvolved image shows localization of pMunc18-1 S241 in a subset of SYN+ terminals in CA1. Plot shows the intensityfrequency distribution for pMunc18-1 immunofluorescence in SYN+ terminals (h): WIN caused a modest right shift denoting increased presynaptic immunoreactivity (i; 2-way ANOVA, P < 0.0001, F 19,342 = 5.54). (j) Numbers of terminals with intense pMunc18-1 immunoreactivity (>100 units fluorescence intensity) for the CA1 S-C field (left) and the DG LPP field (right): WIN increased the numbers of densely pMunc18-1+ terminals in CA1 (**P = 0.0037, t (18) = 3.33) but not in the LPP (P = 0.87, t (18) = 0.62). LTP was evaluated 55-60 min after induction in a-g. Group sizes: n = 6 for veh and n = 7 for WIN in a-g and n = 10 in h and i; 2-tail t-test unless specified.
Therefore, we tested if physostigmine increases hippocampal 2-AG levels, as anticipated, and then used the FDT technique employed above to determine if it also triggers Munc18-1 S241 phosphorylation in the LPP. Infusion of physostigmine (10 μM, 40 min) elicited a marked increase in slice levels of 2-AG (P = 0.01; Fig. 3a) but not other lipids (see Supplementary Fig. S2a) ; it also produced a reliable increase in SYN+ terminals with dense concentrations of pMunc18-1 in both LPP (P = 0.009; Fig. 3b ) and S-C (see Supplementary Fig. S2b ) fields. As predicted, physostigmine effects on both projections were dramatically reduced in slices prepared from Munc18-1 +/− mice relative to those from wild types (LPP P = 0.03, Fig. 3c ; see Supplementary Fig. S2c for CA1) although the mutation had no effect on the input/output (I/O) curve or paired-pulse facilitation in the LPP (see Supplementary  Fig. S2d,e) . A recent study showed that the locally synthesized neurosteroid pregnenolone reduces both CB 1 R signaling through ERK1/2 and neurotransmitter release suppression normally mediated by the ECB receptor (Vallee et al. 2014 ). We tested for this effect in hippocampus beginning with the pronounced fEPSP depression produced by CB 1 R activation in the S-C system: treatment with 10 μM pregnenolone prevented the synaptic response depression elicited by WIN (P = 0.0001; Fig. 3d ). Pregnenolone was similarly effective in the LPP where it blocked actions of physostigmine on presynaptic pMunc18-1 immunoreactivity (P = 0.01; Fig. 3e ) and synaptic transmission (P = 0.03; Fig. 3f ).
These findings point to the conclusion that the pregnenolone/ CB 1 R/Munc18-1 system, as found in the S-C projections, is present in the LPP although it is not engaged by either the CB 1 R agonist WIN or repetitive afferent activity. There remains the possibility, however, that it is activated by the short high-frequency gamma trains used to induce lppLTP and participates in subsequent stabilization of the potentiated state of LPP terminals. We conducted multiple tests of this argument. Pregnenolone at the concentration (10 μM) that eliminates physostigmine effects on transmission and pMunc18-1 immunoreactivity in CA1 had no detectable effect on lppLTP induced by near threshold stimulation (Fig. 3g) . Conventional stimulation trains failed to influence Munc18-1 phosphorylation in LPP terminals (Fig. 3h) and induction of lppLTP was fully intact in Munc18-1 +/− mice (Fig. 3i ). Considered together with evidence that lppLTP is both 2-AG and CB 1 R-dependent (e.g., blocked by CB 1 R antagonists AM215 and SR141716A, absent in CB 1 R KOs, and augmented by increases in 2-AG) (Wang et al. 2016) , the present results suggest that potentiation in the LPP involves a second CB 1 R signaling pathway that has not been evaluated in work using physiological activation of hippocampal synapses. Finally, the results obtained with pregnenolone afforded a means for testing if increases in 2-AG content produced by physostigmine promote lppLTP in the absence of the response suppression associated with Munc18-1 phosphorylation. We tested this intriguing point and found that physostigmine more than doubled the magnitude of lppLTP induced by threshold level stimulation (P = 0.012; Fig. 3j ). This result is consistent with our earlier observation that reducing 2-AG breakdown, and thereby increasing hippocampal slice 2-AG levels, with the monoacylglycerol lipase (MGL) inhibitor JZL184 similarly augments lppLTP (Wang et al. 2016) .
CB 1 R Signaling in LPP Terminals
Prior results showed that lppLTP is blocked by presynaptic actions of latrunculin A (Wang et al. 2016 ), a toxin that selectively blocks the assembly of actin filaments. This raises the possibility that the CB 1 R promotes lppLTP via actions on actin regulatory signaling, an idea in alignment with evidence that CB 1 R initiates actin reorganization in dissociated cells (Roland et al. 2014; Njoo et al. 2015) and rapidly (~2 min) activates both FAK and the small GTPase RhoA in N18TG2 neuroblastoma cells (Dalton et al. 2013) . FAK is a non-receptor tyrosine kinase that mediates integrin effects on the actin cytoskeleton throughout the body (Fabry et al. 2011) . Other experiments found that CB 1 R acting through FAK initiates actin remodeling in pancreatic cells resulting in enhanced insulin release (Malenczyk et al. 2013 ). Accordingly, we used FDT to test if WIN activates FAK, via Y397 phosphorylation, in LPP terminals (Fig. 4a) .
WIN produced a pronounced rightward skew in the immunofluorescence intensity-frequency distribution for pFAK Y397 co-localized with SYN (P < 0.0001; Fig. 4b Costa et al. 2013 ). In the LPP terminal field, WIN increased levels of pROCK S1366 (Chuang et al. 2012 ) co-localized with SYN (P < 0.0001; Fig. 4c) but not with the postsynaptic density marker PSD-95 (P = 0.74; Fig. 4d ). In the same hippocampal slices, WIN increased presynaptic pROCK levels in CA1 but this effect was substantially smaller than that in the LPP. We quantified the regional difference by converting the data into cumulative probability curves and then subtracting the WINtreatment values at each density bin for each slice from the mean curve for the vehicle group. The rightward shift in pROCK immunolabeling produced by WIN was over 2-fold greater in the LPP than in CA1 (P < 0.0001, F 17,23 = 6.105, 2-way ANOVA). In all, the CB 1 R agonist WIN had a much greater effect on Munc18-1 Figure 3 . Biased CB 1 R signaling to Munc18-1 is present in the LPP and modulated by pregnenolone. (a-c) Treatment of acute hippocampal slices with physostigmine (Phys; 10μM) (a) increased 2-AG content (nmol/mg protein) in hippocampus (P = 0.01, t (17) = 2.49, 1-tail t-test; veh n = 9, Phys n = 10), (b) increased numbers of SYN immunopositive (+) terminal boutons enriched in pMunc18-1 S241 in the LPP field, as determined by FDT (P = 0.009, t(22) = 2.51, 1-tail t-test; n = 12 ea), and (c) depressed LPP synaptic responses (fEPSPs) in slices from wild type mice but not from Munc18-1 heterozygotes (Munc18 +/− ) (P = 0.03, t (10) = 2.54; n = 6 ea). (d) Pregnenolone (Preg, 10 μM) blocked the otherwise robust suppression of field CA1 S-C responses achieved with WIN infusion (P = 0.0001, t (9) = 6.47; WIN n = 7, Preg + WIN n = 4; WIN infused 50 min, Preg infused 80 min). (e-g) Pregnenolone (e) blocked physostigmine-induced increases in SYN+ boutons enriched in pMunc18-1 in the LPP field (P = 0.01, F2,33 = 4.91, 1-way ANOVA; with Bonferroni's post-test, veh vs. phys: P < 0.05, phys vs. preg+phys: P < 0.05; n = 12 ea) and (f) blocked suppression of LPP fEPSPs otherwise achieved by infusion of physostigmine (P = 0.03, t (10) = 2.54; Phys n = 7, Phys+Preg: n = 6), but (g) did not impair lppLTP achieved with near threshold HFS (P = 0.33, t (10) = 1.02; n = 6 ea). (h) HFS, relative to LFS, had no effect on pMunc18-1 S241 in LPP terminals (P = 0.77, t (17) = 0.30; LFS n = 10, HFS n = 9). (i) lppLTP was comparable in wild type and Munc18-1 heterozygotes in response to conventional suprathreshold (HFS vs. LFS) (P = 0.80, t (14) = 0.26; wild types n = 7, Munc18-1 +/− n = 9); traces at right show representative fEPSPs for wild types (gray) and Munc18-1 hets (black) during the baseline period. (j) Physostigmine alone depressed LPP synaptic responses; under these conditions, HFS caused a small lppLTP effect. Pregnenolone blocked the depressive effect of physostigmine on baseline LPP responses and uncovered a facilitatory action of the latter on lppLTP in experiments using near threshold HFS (P = 0.0015, F 2,18 = 9.98, 1-way ANOVA; Bonferroni's post-test, preg vs. phys: P < 0.05, phys vs. preg + phys: P < 0.01; preg: phys n = 6, preg + phys n = 7). Electrophysiological results are from field recordings; HFS applied at upward arrows. *P < 0.05 versus veh, # P < 0.05 versus physostigmine; 2-tail t-test unless specified.
phosphorylation in CA1 than in the LPP (Fig. 1i) and a much greater effect on markers of actin signaling in the LPP than in CA1. We conclude from this that the CB 1 R response to WIN is biased toward different signaling streams in the 2 projections. We further tested if CB 1 R signaling to ROCK is more prominent in the LPP than in CA1 using physostigmine to elevate 2-AG levels and signaling. Physostigmine produced a reliable increase in presynaptic pROCK (i.e., a right shift in the density frequency distribution for SYN co-localized pROCK) in the LPP that was blocked by CB 1 R antagonism (P < 0.0001; Fig. 4e ) but had no reliable effect on presynaptic pROCK levels in CA1 of the same hippocampal slices (P = 0.59; Fig. 4f) . A similar pattern of results was obtained in an analysis of the most densely pROCK immunoreactive terminal boutons (Fig. 4 g,h) .
Collectively, these results describe a CB 1 R-FAK-ROCK route by which 2-AG generated and released during high-frequency stimulation (HFS) could facilitate presynaptic cytoskeletal changes required for production of stable lppLTP. In accord with this proposal, high-frequency bursts of LPP stimulation caused a rightward shift in the density frequency distribution of presynaptic pFAK in slices harvested 2 min after stimulation. The effect was blocked by AM251 at the concentration that (e-h) Hippocampal slices were treated with 10 μM physostigmine (Phys) or vehicle for 60 min and then harvested for FDT analysis of pROCK2 in S-C and LPP terminals. (e and f) Physostigmine caused a right shift in the intensity-frequency distribution of presynaptic (SYN colocalized) pROCK that was reduced by AM251 in LPP terminals (e; 2-way ANOVA, P < 0.0001, F 38,855 = 3.40); this effect was not present in CA1 (f; 2-way ANOVA, P = 0.59, F 38,855 = 0.93). (g and h) Percent SYN+ terminals containing dense pROCK immunoreactivity (≥100 units) normalized to the value for control (veh) slices. Physostigmine increased densely pROCK+ terminals and this was blocked by AM251 for the LPP (g; P = 0.0015, F2,47 = 5.86, 1-way ANOVA; Bonferroni's post-test, veh vs. Phys: P < 0.01, Phys vs. Phys+AM251: P < 0.05, n = 16 ea.) but not in CA1 (h; P = 0.57, Percent of SYN+ terminals containing dense immunofluorescence (≥100 units) for pFAK (k) or pROCK (l) normalized to the value for control (LFS) slices. HFS increased numbers of such densely labeled terminals for both antigens and this was blocked by AM251 in both cases (for pFAK P = 0.017, F 2,28 = 4.76; post-test: LFS vs. HFS: P < 0.05; HFS vs. HFS+AM251: P < 0.05; n = 9-10 slices/group; for pROCK P < 0.0001, F 2,61 = 26.92; post-test: LFS vs. HFS: P < 0.001; HFS vs. HFS+AM251: P < 0.001, n = 20-21 slices/group; 1-way ANOVA and Bonferroni's post-test for both). *P < 0.05, **P < 0.01 versus veh or LFS; # P < 0.05, ### P < 0.001 versus Phys or HFS.
blocks lppLTP (P < 0.0001; Fig. 4i,k) . Similar CB 1 R-dependent effects of HFS were obtained for pROCK (Fig. 4j,l) . Finally, perfusion with FAK antagonist Y15 (40 μM) or ROCK inhibitor H1152 (0.1 μM) disrupted lppLTP without affecting baseline responses (veh vs. Y15:70.8 ± 2.3% vs. 26.2 ± 5.1%, P < 0.0001, t (10) = 9.53; veh vs. H1152:59.8 ± 8.6% vs. 25.5 ± 3.9%, P = 0.0047, t (10) = 3.62; n = 6 ea, 2-tail t-test).
Together, these results describe a second CB 1 R signaling pathway in LPP terminals that, unlike the ERK1/2-Munc18-1 route, is directly involved in the production of lppLTP.
β1 Integrins are Critical for lppLPP An important question raised by the above results is why activation of FAK and ROCK by pharmacological CB 1 R stimulation, augmented lppLTP but did not by itself induce potentiation. One possibility is that electophysiological stimulation of the LPP engages elements that are not downstream from CB 1 R activation but nonetheless are required for shifting LPP terminals into the enhanced release state. We tested if integrin class adhesion proteins, which co-operate with CB 1 R in actin regulatory signaling in cultured cells (Dalton et al. 2013) , fill this critical role. Integrins are dimeric transmembrane adhesion receptors for extracellular matrix and cell surface proteins that are expressed throughout the brain by neurons and glia (Park and Goda 2016) . In hippocampus the majority of integrins contain the β1 subunit (Pinkstaff et al. 1999 ) and β1 integrins have been localized to both pre-and postsynaptic compartments (Schuster et al. 2001; Park and Goda 2016) . We previously demonstrated that, in hippocampal slices, infusion of β1 neutralizing antisera disrupts activity-induced actin polymerization and LTP in field CA1 (Kramar et al. 2006 ). Here, we tested if similar treatments influence potentiation in the LPP. Treatment with anti-β1 had no effect on baseline LPP responses but caused a near complete suppression of lppLTP (P < 0.0001; Fig. 5a ). In contrast, neutralizing anti-αV integrin left potentiation intact (P = 0.43; Fig. 5b ). We then assessed lppLTP in slices from conditional β1 KO mice. For these studies, mice with floxed β1 exon 3 (B6;129-Itgb1tm1Efu/J strain) were crossed with CaMKIIα-Cre mice (B6.Cg-Tg(Camk2a-cre)T29-firstl/J) to generate KOs with β1 expression depressed in excitatory hippocampal neurons beginning in the third week of life (Wang et al. 2016a ). The LPP I/O curve in β1 KOs was slightly depressed relative to wild types but this effect did not approach statistical significance (P = 0.17; Fig. 5c ). Waveform characteristics were also comparable between KOs and wild types (Fig. 5c, inset) ; quantitatively, the mean time constants for the rising and decay phases of the fEPSP were not detectably different. Despite seemingly normal fEPSPs, the β1 KOs had severely impaired lppLPP (P = 0.005; Fig. 5d) .
A major subset of β1 family integrins bind an Arg-Gly-Asp (RGD) consensus sequence in their matrix ligands (Humphries et al. 2006) . Snake toxin "disintegrins," including echistatin, contain an RGD mimetic sequence that blocks this integrin subgroup. We confirmed that infusion of echistatin blocks the stabilization of postsynaptic LTP in field CA1 (P = 0.0012; Fig. 5e ), as previously reported (Chun et al. 2001) , and then tested for effects on lppLTP. Echistatin had no detectable influence on lppLTP measured 55-60 min postinduction (P = 0.628; Fig. 5f ). We compared the results obtained with the various integrin manipulations by normalizing the percent lppLTP per experimental slice to the mean value for yoked vehicle cases. There was a highly significant group effect for treatment (P = 0.0003; Fig. 5g ) with measures of potentiation from the anti-β1 group being lower than those from control, anti-αV, or echistatin groups (***P < 0.001, **P < 0.01). The anti-αV and echistatin Figure 5 . Production of lppLTP is β1-integrin dependent. (a-g) Hippocampal slices received stimulation of LPP or S-C projections ("e" only) to assess the effects of pharmacological or genetic manipulation of integrins on plasticity. (a) Infusion of neutralizing anti-β1-integrin blocked stabilization of lppLTP while the control immunoglobulin (IgG) had no effect (P < 0.0001, t(11) = 7.21; IgG n = 6, anti-β1 n = 7). (b) Neutralizing anti-αV integrin did not affect lppLTP (P = 0.43, t(9) = 0.83; IgG n = 6, anti-αV n = 5). (c) The fiber volley amplitude versus fEPSP amplitude relationship (I/O curve) for wild types and conditional β1-integrin KO mice were comparable (2-way ANOVA, P = 0.17, F 5,65 = 1.63; wild type n = 10, β1 KO n = 13); inset shows representative fEPSP traces. (d) High-frequency LPP stimulation induced comparable initial potentiation in wild type and β1 KO mice but the level of potentiation then fell steadily toward baseline in KOs only (P = 0.005, t (21) = 3.18; wild type n = 10, β1 KO n = 13). (e and f) The disintegrin echistatin (10 μM) blocked LTP in CA1 (e; P = 0.0012, t(9) = 4.63; veh n = 4, echistatin n = 7) but had no effect on lppLTP (f; P = 0.628, t(8) = 0.504; veh n = 6, echistatin n = 7). (g) Summary graph shows the magnitude of lppLTP after integrin-targeted manipulations % potentiation vs. baseline for individual slices, normalized to paired control group means; P = 0.0003, F 3,17 = 11.19, 1-way ANOVA and Bonferroni's Multiple Comparison Test. The percent of SYN+ boutons associated with dense pPyk2 immunolabeling (≥92 intensity) in the LPP field normalized to the value for control slices: (h) HFS produced a robust increase relative to LFS (P = 0.012, t (22) = 2.74; n = 12 ea) while (i) WIN had no effect relative to vehicle (P = 0.87, t(22) = 0.17; veh n = 13, WIN n = 11). **P < 0.01, ***P < 0.001; 2-tail t-test unless otherwise specified. treatment groups exhibited potentiation that did not differ from each other or from controls.
Next, we tested for integrin signaling that is activated by HFS but not by pharmacological activation of the CB 1 Rs. A likely additional factor is proline-rich tyrosine kinase-2 (Pyk2), a second integrin-associated tyrosine kinase that produces downstream effects beyond those targeted by the homologous FAK (Girault et al. 1999) . Physiological stimulation increased the number of terminals with high density pPyk2 immunolabeling (P = 0.012; Fig. 5h ). In contrast, WIN did not affect the percentage of LPP terminals with dense concentrations of pPyk2 (P = 0.87; Fig. 5i ). These findings point to a hypothesis in which high-frequency LPP stimulation activates β1 family integrins and their signaling to 2 associated tyrosine kinases, one of which (FAK) is targeted by 2-AG signaling through the CB 1 R. This co-operative signaling then produces the presynaptic cytoskeletal changes required for lasting increases in transmitter release.
Activation of synaptic integrin signaling by physiological activity is reported to involve ligands generated from the extracellular matrix by metalloproteinases (MMPs), and by MMP9 in particular (Nagy et al. 2006) . We tested for involvement of this mechanism in the LPP and found that perfusion of the broad MMP inhibitor GM 6001 (25 μM) produced a significant impairment of lppLTP (veh 70.1 ± 4.7%; GM6000 40.9 ± 3.6%; P = 0.0006, t (10) = 4.94, 2-tail t-test, n = 6 ea) without effect on baseline responses.
LPP-Dependent Learning Induces lppLTP
Lateral entorhinal cortex neurons that generate the LPP receive dense input from the adjacent olfactory (piriform) cortex and neocortical associational regions. Prior studies confirmed that the LPP is critical for learning two-odor discriminations (Staubli et al. 1984; Otto et al. 1991) and, more recently, that AM251 blocks this encoding whereas suppression of 2-AG degradation enhances it (Wang et al. 2016) . We accordingly used the 2-odor paradigm to test if learning elicits signaling associated with the production of lppLTP. Rats were trained on a series of ten novel discriminations over successive days until they showed a strong preference for the positive cue in trials 6-10. Past work showed that such learning results in long-term memory (Larson et al. 1995) . A novel odor pair was presented on the test day. Animals were euthanized immediately after the 10th training trial and sections through rostral hippocampus (Fig. 6a) were processed for dual immunostaining (SYN and pROCK) and FDT analysis:~400 000 SYN+ structures fitting the size and eccentricity constraints of synapses were reconstructed in 3D from image z-stacks in the LPP field within the outer molecular layer of the DG. The data were expressed as percent of all bouton-sized SYN clusters for each of a series of increasing pROCK density bins. The immunofluorescence intensity-frequency distribution for SYN co-localized pROCK was skewed to the right for rats trained in the olfactory discrimination relative to untrained controls (P < 0.0001; Fig. 6b ), indicating that the learning group had greater concentrations of pROCK in LPP terminals (LPP afferents comprise over 80% of the innervation in this lamina). Increases in pROCK immunolabeling produced by odor learning were eliminated by AM251 (1 mg/kg) given 1 h before training (P < 0.0001; Fig. 6b ).
There was a small but significant difference in the total number of SYN clusters in the AM251 group relative to the odor learning plus vehicle (−5.9%, P < 0.01, t-test) or control (−6.7%, P < 0.04) animals. To minimize any effects of this, we recalculated the above data for each pROCK density bin for each animal as a percentage of all double-labeled contacts for that animal, with the results expressed as a cumulative probability function. The mean curve for the learning plus vehicle group was clearly displaced to the right relative to that for the learning plus AM251 or for control rats (RM-ANOVA: P < 0.0001 in each case); the results for the latter 2 groups were superimposed on each other (Fig. 6c) . A bootstrap analysis (Stein 1989) using randomly selected pairs of animals (1000 pairs per run; 15 runs) confirmed that the summed deviations between curves were much greater for learning versus control groups (20×) than for the learning + AM251 versus control groups (3×) (P < 0.0001, t-test).
Discussion
The present studies provide a first detailed description of the mechanisms underlying a novel form of LTP in a primary cortical input to hippocampus. Given that this projection conveys semantic ("what is it") information to hippocampus (Eichenbaum et al. 2012; Reagh and Yassa 2014) , the findings are of basic importance to Figure 6 . Learning of cues conveyed by the LPP produces synaptic effects associated with lppLTP. (a) Location of DG molecular layer sample zones for measures of SYN co-localized pROCK. (b) Phospho-ROCK labeling co-localized with SYN is described as a percent of the total population of bouton-sized SYN clusters for each of an ascending series of pROCK density bins. The resultant distribution (means ± SEMs) is right-skewed in vehicle treated rats after learning a novel odor pair (learnveh, n = 16) relative to the transport "control" group (n = 17) (P < 0.0001, F24,720 = 5.14, 2-way ANOVA, control vs. learn-veh); this effect was blocked by AM251 (n = 8) (P < 0.0001, F24,528 = 2.61, 2-way ANOVA, learn-veh vs. learn-AM251). (c) The data for pROCK density bins for each animal were calculated as % of all double-labeled synapses for that animal (rather than as % total SYN positive boutons) and the results plotted as cumulative probability functions. The mean (±SEMs) curve for the learning-veh group was again displaced from those for the control group (P < 0.0001; F 24,696 = 5.020, 2-way RM-ANOVA) and learning animals treated with AM251 (P < 0.0001; F24,528 = 4.481, 2-way RM-ANOVA). The cumulative probability curves for the latter 2 groups (control and learning-AM251) could not be distinguished. the development of neurobiologically based theories of episodic memory. The substrates for lppLTP include a repurposing of elements utilized in conventional, postsynaptic potentiation, as described for the intensively studied S-C projection to CA1, supplemented with novel features. Both forms of potentiation are induced postsynaptically via NMDARs and increased calcium levels (Collingridge et al. 1983; Lynch et al. 1983; Granger and Nicoll 2014) , and both require activation of β1 integrins and their downstream effector ROCK (Chan et al. 2006; Kramar et al. 2006; Rex et al. 2009 ). Integrins are a primary membrane regulator of the actin cytoskeleton (DeMali et al. 2003) and their prominent role in both types of plasticity suggests that activity-induced structural changes constitute a shared endpoint. Potentiation of S-C synapses in field CA1 entails integrin-driven assembly of stable actin networks in dendritic spines and an associated shift in spine/synapse morphology (Kramar et al. 2006; Chen et al. 2007; Rudy 2015) . Morphometric studies have yet to be performed for lppLTP but results obtained with the toxin latrunculin A, which selectively blocks actin filament assembly, confirm that in this system the cytoskeletal reorganization is located presynaptically (Wang et al. 2016) . Thus, integrin regulation of the cytoskeleton, via signaling common to cell adhesion junctions throughout the body, underlies both forms of potentiation but in the case of lppLTP these processes are active on the presynaptic side. This specialized feature of the LPP results in a new form of LTP.
Earlier work showed that LTP induction in the LPP requires stimulation of mGluR5 receptors, something that was not the case for field CA1 or the medial perforant path (Wang et al. 2016) . The mGluR5 receptor forms a postsynaptic signalosome with the scaffolding protein Homer and the 2-AG synthesizing enzyme diacylglycerol lipase-α (DAGL-α) (Jung et al. 2012 ). Activation of this unit results in de novo 2-AG production and retrograde signaling to presynaptic CB 1 Rs, 2 events shown to be essential for lppLTP (Wang et al. 2016 ). The present results establish that this dependency is not due to canonical CB 1 R signaling, which produces depression of transmitter release (Castillo et al. 2012 ) at sites throughout the brain. Instead, the critical contribution of CB 1 Rs to lppLTP involves activation of the integrin-associated kinase FAK and its downstream effector ROCK with high-frequency afferent activity. We found that the CB 1 R inverse agonist AM251 prevented such activation, whereas the CB 1 R agonist WIN mimicked it and also lowered the threshold for induction of lppLTP. Conversely, the release depression function of the CB 1 R was poorly developed in the LPP and not involved in the potentiation effect. ECB-mediated release suppression is reportedly sensitive to locally synthesized pregnenolone (Vallee et al. 2014 ) and involves phosphorylation of the vesicular protein Munc18-1 (Schmitz et al. 2016) . These effects were evident in S-C projections to CA1 but not in the LPP. Specifically, treatment with CB 1 R agonist WIN increased phosphorylation of Munc18-1 and caused a Munc18-1 dependent, pregnenolone-sensitive depression of synaptic responses in field CA1. In contrast, neither pregnenolone nor reductions in Munc18-1 expression affected lppLTP. We propose that a shift in the bias of CB 1 R signaling away from the Munc18-1 pathway and toward facilitation of the ROCK/FAK, integrin signaling cascade constitutes a projection system-specific specialization that enables the thus far singular form of LTP found in the LPP (Fig. 7) .
There is precedence for both ligand-and cell-type-specific differences in CB 1 R signaling Laprairie et al. 2014) . Ligands for CB 1 R, including the ECBs, synthetic cannabinoids such as WIN and phytocannabinoids such as Δ 9 -tetrahydrocannabinol, all bind different residues on the receptor. This has been suggested to give rise to ligand-specific conformational changes in CB 1 R leading to activation of different downstream signaling pathways Varga et al. 2008; Hudson et al. 2010) . Moreover, the functional selectivity of a given ligand can be cell-type-specific (Bosier et al. 2010) . In line with these observations, we found cell-type-specific differences in CB 1 R-mediated responses to a given ligand (e.g., WIN depressed baseline transmission in CA1 but not in the LPP) and differences in CB 1 R response to different ligands for a given cell-type (e.g., the robust 2-AG signaling induced by physostigmine increased LPP pMunc18-1 and suppressed LPP baseline responses whereas WIN elicited neither effect).
The evidence for projection-specific differences in CB 1 R signaling gives rise to the prediction that modulation of synaptic transmission by ECBs during behaviorally relevant patterns of synaptic activity, a topic that has received surprisingly little attention, will differ between the S-C and LPP systems. Tests confirmed that stimulation in the low-frequency gamma (40 Hz) range, selected to simulate the activity in fields CA3 and CA1 during exploration (Colgin 2015) , engages CB 1 Rs to depress synaptic responses generated by the S-C, but not LPP, projections. Thus, the projection-specific bias in CB 1 R function is likely to differentially influence throughput across the nodes of the primary hippocampal network. An interesting issue for future research concerns the extent to which the contribution of ECBs to synaptic function is frequency-tuned and differs across hippocampal rhythms (beta, gamma, theta, etc.) associated with various behaviors.
Prior work showed that blocking or enhancing the production of 2-AG produces corresponding effects on both the magnitude of lppLTP and the encoding of olfactory cues carried to hippocampus by the LPP system (Wang et al. 2016) . The present experiments demonstrate that olfactory discrimination learning elicits evidence for potentiation in the form of increased presynaptic pROCK within the LPP. Questions thus arise about the functional significance of using a specialized form of plasticity to encode the semantic ("what") information carried by the LPP. One possibility is that the specialization helps to maintain cue identity through downstream hippocampal processing. The novel lppLTP effect changes the frequency facilitation characteristics of the LPP, as evidenced by paired-pulse measurements, something that would be expected to alter the spiking response of granule cells to patterned input. This would serve to differentiate the DG outputs produced by learned versus unlearned cues and help maintain cue identity through downstream processing. It would also further distinguish the response of granule cells to input arriving over the LPP from those elicited by the subjacent medial perforant path (spatial information). Related to this, insertion of a 2-AG step in the mechanisms for encoding opens the way for modulation of lppLTP by afferents arising from sites other than entorhinal cortex. Cholinergic inputs from the medial septum and diagonal bands are of particular interest in this regard because enhancing constitutive transmission in this projection elevates 2-AG levels and related CB 1 R signaling in terminals. We used this effect to confirm that the Munc18-1 release suppression system is present in the LPP although not engaged by WIN or afferent stimulation. The studies also demonstrated that increasing cholinergic transmission has a strong positive effect on the production lppLTP, particularly when release suppression machinery is blocked with pregnenolone. It is, therefore, possible that particular patterns of firing by septal afferents or levels of pregnenolone synthesis promote the presynaptic LTP in the LPP while depressing the postsynaptic variant found in the medial perforant path. Such a mechanism could be of value when semantic information has a higher priority than spatial data.
Finally, the present evidence for biased CB 1 R signaling has significant implications for hypotheses about how marijuana influences cognition. The Δ 9 -tetrahydrocannabinol component of cannabis is an agonist for CB 1 Rs and stimulates the production of pregnenolone (Vallee et al. 2014) ; results presented here indicate that the combination of CB 1 R stimulation and high levels of pregnenolone will lower the requirements for robust lppLTP and the encoding of near threshold cues. It is interesting regarding this possibility that marijuana promotes the formation of false memories in episodic memory tests (Riba et al. 2015) . In all, the differential effects of CB 1 R stimulation across the principal nodes of hippocampal circuitry are predicted to underlie a distortion of episodic memory with cannabis exposure that is due to enhanced plasticity in the LPP.
